These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6892773)

  • 21. Studies on phospholipase A inhibitor in blood plasma. II. Interaction of phospholipase A inhibitor with phospholipase A and its specificity.
    Miwa M; Ichihashi T; Motojima H; Onodera-Kubota I; Matsumoto M
    J Biochem; 1985 Jul; 98(1):157-65. PubMed ID: 4044547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of cell-impermeable inhibitor of phospholipase A2.
    Yedgar S; Reisfeld N; Dagan A
    FEBS Lett; 1986 May; 200(1):165-8. PubMed ID: 2422059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
    Filippov A; Skatova G; Porotikov V; Kobrinsky E; Saxon M
    Gen Physiol Biophys; 1989 Apr; 8(2):113-8. PubMed ID: 2777057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of phospholipase A2 by protein I.
    Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM
    Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraventricular injections of drugs which inhibit phospholipase A2 suppress fever in rabbits.
    Cranston WI; Hellon RF; Mitchell D; Townsend Y
    J Physiol; 1983 Jun; 339():97-105. PubMed ID: 6887041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrolysis of phosphatidylcholine liposomes by lysosomal phospholipase A is maximal at the phase transition temperature of the lipid substrate.
    Vandenbranden M; De Gand G; Brasseur R; Defrise-Quertain F; Ruysschaert JM
    Biosci Rep; 1985 Jun; 5(6):477-82. PubMed ID: 4041563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local anesthetics, chlorpromazine and propranolol inhibit stimulus-activation of phospholipase A2 in human platelets.
    Vanderhoek JY; Feinstein MB
    Mol Pharmacol; 1979 Jul; 16(1):171-80. PubMed ID: 384205
    [No Abstract]   [Full Text] [Related]  

  • 28. [A coupled enzyme system for detection of phospholipase A2 inhibitors].
    Köhler T; Landgraf J; Nuhn P
    Pharmazie; 1988 Mar; 43(3):178-84. PubMed ID: 3132726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of coenzyme Q10 on the action of phospholipase.
    Sugiyama S; Hattori M; Nagai S; Takamura T; Ozawa T
    Arzneimittelforschung; 1985; 35(1):23-5. PubMed ID: 4039149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of highly purified mammalian phospholipases A2 by non-steroidal anti-inflammatory agents. Modulation by calcium ions.
    Franson RC; Eisen D; Jesse R; Lanni C
    Biochem J; 1980 Feb; 186(2):633-6. PubMed ID: 7378071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antimalarial drugs on phospholipase A2 [proceedings].
    Authi KS; Traynor JR
    Br J Pharmacol; 1979 Jul; 66(3):496P. PubMed ID: 526765
    [No Abstract]   [Full Text] [Related]  

  • 32. A prostaglandin oligomeric derivative inhibits activities of phospholipase and protease: a possible mechanism of membrane protection during ischemia.
    Ohnishi ST; Katsuoka M; Hidaka S
    Cell Biochem Funct; 1989 Jan; 7(1):51-5. PubMed ID: 2752536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C.
    Simon MF; Chap H; Douste-Blazy L
    Biochim Biophys Acta; 1986 Feb; 875(2):157-64. PubMed ID: 3080024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
    Tanaka N; Kagawa S; Murakoso K; Shimizu S; Matsuoka A
    Horm Metab Res; 1983 May; 15(5):255-6. PubMed ID: 6409772
    [No Abstract]   [Full Text] [Related]  

  • 35. Phospholipase A2 and lipocortin effects.
    Dennis EA; Davidson FF
    Prog Clin Biol Res; 1990; 349():47-54. PubMed ID: 2144646
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of lipid peroxidation in muscle homogenates by phospholipase A2 inhibitors.
    Jackson MJ; Jones DA; Harris EJ
    Biosci Rep; 1984 Jul; 4(7):581-7. PubMed ID: 6478056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase.
    Henderson LM; Chappell JB; Jones OT
    Biochem J; 1989 Nov; 264(1):249-55. PubMed ID: 2557829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory factor of phospholipase A2 in normal human serum.
    Etienne J; Grüber A; Polonovski J
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1117-24. PubMed ID: 6477552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2.
    Davidson FF; Dennis EA
    Biochem Pharmacol; 1989 Nov; 38(21):3645-51. PubMed ID: 2532012
    [No Abstract]   [Full Text] [Related]  

  • 40. Phospholipase A2 hydrolysis of membrane phospholipids causes structural alteration of the nicotinic acetylcholine receptor.
    Villar MT; Artigues A; Ferragut JA; Gonzalez-Ros JM
    Biochim Biophys Acta; 1988 Feb; 938(1):35-43. PubMed ID: 3337815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.